The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Targeted next-generation sequencing (NGS) of germline DNA to identify genetic predisposition to gastric cancer (GC) in patients with CDH1-mutation negative early-onset (EO) or familial GC (FGC).
 
Geoffrey Yuyat Ku
Consulting or Advisory Role - AstraZeneca/MedImmune; Bayer
Research Funding - Arog (Inst); Bristol-Myers Squibb (Inst); MedImmune (Inst); Merck (Inst)
Travel, Accommodations, Expenses - AstraZeneca/MedImmune
 
Semanti Mukherjee
No Relationships to Disclose
 
Chizoba Okoro
No Relationships to Disclose
 
Medha Sharma
No Relationships to Disclose
 
Vignesh Ravichandran
No Relationships to Disclose
 
Kenneth Offit
No Relationships to Disclose
 
Vijai Joseph
Stock and Other Ownership Interests - Juno Therapeutics
 
Yelena Yuriy Janjigian
Consulting or Advisory Role - Lilly; Pfizer
Research Funding - Amgen; Bayer; Boehringer Ingelheim; Genentech; Lilly; Roche
 
Zsofia Kinga Stadler
Consulting or Advisory Role - Adverum (I); Allergan (I); Genentech/Roche (I); Optos (I); Regeneron (I)
 
David Paul Kelsen
No Relationships to Disclose